{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-4/paragraph-29C",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-4/paragraph-29C.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/4/paragraph/29C",
  "kind": "paragraph",
  "number": "29C",
  "heading": "Contact via NHS.net Connect, pharmacy profiles and the Central Alerting System",
  "text": "(1) An NHS pharmacist (P) must ensure that pharmacy staff at pharmacy premises (including locums) have access to, and are able to send and receive messages via NHS.net Connect from, a premises specific NHS.net Connect account.\n(2) P must ensure that at least two members of the pharmacy staff have live, linked NHS.net Connect accounts to the premises specific NHS.net Connect account (unless fewer than two members of the pharmacy staff are engaged in the provision of NHS services).\n(3) P must ensure that there is a comprehensive and accurate pharmacy profile in respect of P’s pharmacy premises in the NHS England directory of services, and P must verify and where necessary update the information contained in that profile at least once each quarter of the financial year.\n(4) P must ensure that there is a comprehensive and accurate pharmacy profile in respect of P’s pharmacy premises on the NHS.uk website, and P must verify and where necessary update the information contained in that profile at least once each quarter of the financial year.\n(5) As regards the Central Alerting System (CAS) operated by the Medicines and Healthcare products Regulatory Agency (MHRA)—\n(a) P must register P’s premises specific NHS.net Connect address with MHRA as an address at which P is content to accept notifications as part of the CAS (unless they are content with the address already in the system);\n(b) if P changes P’s premises specific NHS.net Connect address, P must immediately notify MHRA of P’s new premises specific NHS.net Connect address, in accordance with paragraph (a); and\n(c) P must monitor P’s premises specific NHS.net Connect account with sufficient frequency to ensure the safe and effective supply of medicinal products at or from P’s pharmacy premises, and must act on the alerts P receives as part of the CAS, as appropriate.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. 4 paras. 29B, 29C inserted (9.11.2020) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020 (S.I. 2020/1126), regs. 1(2), 17"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Sch. 4 para. 29C(1) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(b)(i)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Sch. 4 para. 29C(1) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(b)(ii)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Words in Sch. 4 para. 29C(2) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(c)"
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Words in Sch. 4 para. 29C(3) substituted (1.2.2023) by The Health and Social Care Information Centre (Transfer of Functions, Abolition and Transitional Provisions) Regulations 2023 (S.I. 2023/98), reg. 1(2), Sch. para. 47(3)(b) (with reg. 3)"
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Words in Sch. 4 para. 29C(5)(a) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(d)(i)"
    },
    {
      "type": "F",
      "label": "F7",
      "text": "Words in Sch. 4 para. 29C(5)(b) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(d)(ii)"
    },
    {
      "type": "F",
      "label": "F8",
      "text": "Words in Sch. 4 para. 29C(5)(c) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(d)(iii)"
    },
    {
      "type": "F",
      "label": "F9",
      "text": "Words in Sch. 4 para. 29C heading substituted (1.10.2025) by virtue of The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 64(3)(a)"
    }
  ],
  "outstanding_effects": [
    {
      "type": "inserted",
      "affecting": "uksi/2026/961",
      "affecting_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/4/paragraph/29C",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}